Jundishapur Journal of Microbiology

Published by: Kowsar

The Frequency, Antifungal Susceptibility and Enzymatic Profiles of Candida Species Isolated from Neutropenic Patients

Maral Gharaghani 1 , 2 , Ali Rezaei-Matehkolaei 1 , 2 , Ali Zarei Mahmoudabadi 1 , 2 , * and Bijan Keikhaei 3
Authors Information
1 Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Health Research Institute, Thalassemia and Hemoglobinopathy Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Jundishapur Journal of Microbiology: November 2016, 9 (11); e60179
  • Published Online: October 9, 2016
  • Article Type: Research Article
  • Received: August 12, 2016
  • Revised: September 18, 2016
  • Accepted: September 27, 2016
  • DOI: 10.5812/jjm.41446

To Cite: Gharaghani M, Rezaei-Matehkolaei A, Zarei Mahmoudabadi A, Keikhaei B. The Frequency, Antifungal Susceptibility and Enzymatic Profiles of Candida Species Isolated from Neutropenic Patients, Jundishapur J Microbiol. 2016 ; 9(11):e60179. doi: 10.5812/jjm.41446.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Gharagozlou M, et al. Neutropenia in patients with primary antibody deficiency disorders. Iran J Allergy Asthma Immunol. 2004; 3(2): 77-81[PubMed]
  • 2. Walsh TJ, Gamaletsou MN. Treatment of fungal disease in the setting of neutropenia. Hematology Am Soc Hematol Educ Program. 2013; 2013: 423-7[DOI][PubMed]
  • 3. Link H, Bohme A, Cornely OA, Hoffken K, Kellner O, Kern WV, et al. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol. 2003; 82 Suppl 2-17[DOI][PubMed]
  • 4. van Burik JAH, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH, et al. Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation. Clinical Infectious Dis. 2004; 39(10): 1407-16[DOI]
  • 5. Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S, et al. 1,3-D-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia. Clinical Infectious Dis. 2008; 46(6): 878-85[DOI]
  • 6. Spiess B, Seifarth W, Hummel M, Frank O, Fabarius A, Zheng C, et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol. 2007; 45(11): 3743-53[DOI][PubMed]
  • 7. Vardakas KZ, Michalopoulos A, Falagas ME. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. Br J Haematol. 2005; 131(1): 22-8[DOI][PubMed]
  • 8. Meurman J, Siikala E, Richardson M, Rautemaa R. Non-Candida albicans Candida yeasts of the oral cavity. Communicating current research and educational topics and trends in applied microbiology Microbiology book series Badajoz. 2007; : 719-31
  • 9. Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez JA, Teppler H, et al. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients. Cancer. 2006; 106(2): 466-73[DOI][PubMed]
  • 10. Vazin A, Davarpanah MA, Ghalesoltani S. Antifungal agent utilization evaluation in hospitalized neutropenic cancer patients at a large teaching hospital. Drug Healthc Patient Saf. 2015; 7: 97-102[DOI][PubMed]
  • 11. Waltimo T, Kuusinen M, Jarvensivu A, Nyberg P, Vaananen A, Richardson M, et al. Examination on Candida spp. in refractory periapical granulomas. Int Endod J. 2003; 36(9): 643-7[PubMed]
  • 12. Merseguel KB, Nishikaku AS, Rodrigues AM, Padovan AC, e Ferreira RC, de Azevedo Melo AS, et al. Genetic diversity of medically important and emerging Candida species causing invasive infection. BMC Infect Dis. 2015; 15: 57[DOI][PubMed]
  • 13. Seifi Z, Zarei Mahmoudabadi A. Extracellular Esterase Secretion by Vaginal Isolates of Candida Albicans. Jentashapir J Health Res. 2014; 5(4)[DOI]
  • 14. Seifi Z, Zarei Mahmoudabadi A, Zarrin M. Extracellular enzymes and susceptibility to fluconazole in Candida strains isolated from patients with vaginitis and healthy individuals. Jundishapur J Microbiol. 2015; 8(3): 20162[DOI][PubMed]
  • 15. Zarrin M, Rajabi M, Zarei Mahmoudabadi A. Study of haemolytic, esterase activities and germ tube formation in Candida albicans from patients with vaginitis and urinary infections. Brunei Int Med J. 11(4): 191-6
  • 16. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982; 20(1): 7-14[PubMed]
  • 17. Refrence method for broth dilution abtifungal suceptibility testing of yeasts; approved standard-third edition. M27-A3. 28(14)
  • 18. Scherr N, Roltgen K, Witschel M, Pluschke G. Screening of Antifungal Azole Drugs and Agrochemicals with an Adapted alamarBlue-Based Assay Demonstrates Antibacterial Activity of Croconazole against Mycobacterium ulcerans. Antimicrobial Agents Chemo. 2012; 56(12): 6410-3[DOI]
  • 19. Repp KK, Menor SA, Pettit RK. Microplate Alamar blue assay for susceptibility testing ofCandida albicansbiofilms. Med Mycol. 2007; 45(7): 603-7[DOI]
  • 20. Kauffman CA. Candiduria. Clinical Infectious Dis. 2005; 41[DOI]
  • 21. Georgiadou SP, Tarrand J, Sipsas NV, Kontoyiannis DP. Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker? Mycoses. 2013; 56(3): 311-4[DOI][PubMed]
  • 22. Haddadi P, Zareifar S, Badiee P, Alborzi A, Mokhtari M, Zomorodian K, et al. Yeast colonization and drug susceptibility pattern in the pediatric patients with neutropenia. Jundishapur J Microbiol. 2014; 7(9): 11858[DOI][PubMed]
  • 23. Manzoni P, Farina D, Monetti C, Priolo C, Leonessa M, Giovannozzi C, et al. Early-onset neutropenia is a risk factor for Candida colonization in very low-birth-weight neonates. Diagn Microbiol Infect Dis. 2007; 57(1): 77-83[DOI][PubMed]
  • 24. Zollner-Schwetz I, Auner HW, Paulitsch A, Buzina W, Staber PB, Ofner-Kopeinig P, et al. Oral and intestinal Candida colonization in patients undergoing hematopoietic stem-cell transplantation. J Infect Dis. 2008; 198(1): 150-3[DOI][PubMed]
  • 25. Ashour SM, Kheiralla ZM, Maklad SS, Ameen MR, Zaki SS. Relationship between virulence factors of Candida species with candiduria and myeloperoxidase concentrations. Int J Curr Microbiol App Sci. 2015; 4(1): 108-23
  • 26. Ghiasian SA, Aghamirian MR, Eshghi GR. Nosocomial Candiduria in Critically Ill Patients Admitted to Intensive Care Units in Qazvin, Iran. Avicenna J Clin Micro Inf. 2014; 1(2)[DOI]
  • 27. Zarei Mahmoudabadi A, Zarrin M, Ghanatir F, Vazirianzadeh B. Candiduria in hospitalized patients in educational hospitals of Ahvaz. Iran J Microbiol. 4(4): 15-24
  • 28. Brandt ME, Kauffman CA, Pappas PG, Iqbal N, Arthington-Skaggs BA, Lee-Yang W, et al. Fungemia Caused by Zygoascus hellenicus in an Allogeneic Stem Cell Transplant Recipient. J Clin Microb. 2004; 42(7): 3363-5[DOI]
  • 29. Vervaeke S, Vandamme K, Boone E, De Laere E, Swinne D, Surmont I. A case ofCandida lambicafungemia misidentified asCandida kruseiin an intravenous drug abuser. Med Mycol. 2008; 46(8): 853-6[DOI]
  • 30. Pakshir K, Zomorodian K, Karamitalab M, Jafari M, Taraz H, Ebrahimi H. Phospholipase, esterase and hemolytic activities of Candida spp. isolated from onychomycosis and oral lichen planus lesions. J Mycol Med. 2013; 23(2): 113-8[DOI][PubMed]
  • 31. Negri M, Martins M, Henriques M, Svidzinski TI, Azeredo J, Oliveira R. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia. 2010; 169(3): 175-82[DOI][PubMed]
  • 32. Kumar VG, Latha R, Vedhagiri K, Sathiamoorthi T, Jayarani G, Sasikala R, et al. Phospholipase C, proteinase and hemolytic activities of Candida spp. isolated from pulmonary tuberculosis patients. J de Mycologie Médicale/Journal of Medical Mycology. 2009; 19(1): 3-10
  • 33. Vidotto V, Yumi Koga-Ito C, Milano R, Fianchino B, Ponton J. Correlation between germ tube production, phospholipase activity and serotype distribution in Candida albicans. Rev Iberoam Micol. 1999; 16(4): 208-10[PubMed]
  • 34. Yu DT, Seger DL, Peterson JF, Kumar RN, Bates DW. Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia. BMC Infect Dis. 2006; 6: 173[DOI][PubMed]
  • 35. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med. 1991; 325(18): 1274-7[DOI][PubMed]
  • 36. Rodrigues CF, Silva S, Henriques M. Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis. 2014; 33(5): 673-88[DOI][PubMed]
  • 37. Zhang L, Xiao M, Watts MR, Wang H, Fan X, Kong F, et al. Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy. BMC Infect Dis. 2015; 15: 340[DOI][PubMed]
  • 38. Nucci M, Colombo AL. Emergence of resistant Candida in neutropenic patients. Braz J Infect Dis. 2002; 6(3): 124-8[PubMed]
  • 39. Yenisehirli G, Bulut N, Yenisehirli A, Bulut Y. In Vitro Susceptibilities of Candida albicans Isolates to Antifungal Agents in Tokat, Turkey. Jundishapur J Microbiol. 2015; 8(9): 28057[DOI][PubMed]
  • 40. Shokohi T, Bandalizadeh Z, Hedayati M, Mayahi S. In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents. Jundishapur J Microbiol. 2011; 4(2)-26
  • 41. Rezazadeh E, Sabokbar A, Moazeni M, Rezai M, Badali H. Microdilution in vitro Antifungal Susceptibility Patterns of Candida Species, From Mild Cutaneous to Bloodstream Infections. Jundishapur J Microbiol. 2016; 9(7)[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments